Maria Horn, NP
Acute Care · Centerville, OHNPI 1619521028
Payments from drug & device makers
Across 113 payments — averaging $14.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$737
- Biohaven Pharmaceuticals, Inc.$149
- Lilly USA, LLC$78
- Jazz Pharmaceuticals Inc.$67
- SK Life Science, Inc.$60
- Acadia Pharmaceuticals Inc$52
- plus $467 from 17 others
What the payments were for
- Food & beverage$1,54396%
- Education$674%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $737 |
| Biohaven Pharmaceuticals, Inc. | 15 | $149 |
| Lilly USA, LLC | 5 | $78 |
| Jazz Pharmaceuticals Inc. | 1 | $67 |
| SK Life Science, Inc. | 3 | $60 |
| Acadia Pharmaceuticals Inc | 3 | $52 |
| Acorda Therapeutics, Inc | 3 | $49 |
| UCB, Inc. | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Biogen | 2 | $42 |
| Neurocrine Biosciences, Inc. | 3 | $41 |
| Novartis | 2 | $39 |
| Monteris Medical Corporation | 1 | $28 |
| Amneal Pharmaceuticals LLC | 2 | $25 |
| Sanofi | 1 | $24 |
| Novo Nordisk | 1 | $20 |
| Amgen | 1 | $19 |
| Eisai Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Adamas Pharmaceuticals, Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
How this compares
$1,610 in reported general payments places this provider in the 85th percentile of 1,101 acute care providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 11 | $8,095 |
| Modafinil | 14 | $5,042 |
| Entacapone | 27 | $1,651 |
| Levetiracetam | 33 | $1,109 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 20 | $1,061 |
| Memantine Hcl | 55 | $1,031 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 46 | $947 |
| Armodafinil | 13 | $919 |
| Lacosamide | 16 | $892 |
| Donepezil Hcl | 60 | $716 |
| Pregabalin | 16 | $583 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 14 | $557 |
| Duloxetine Hcl | 18 | $334 |
| Gabapentin | 33 | $278 |
| Primidone | 16 | $216 |
Paid to pharmacies, not to this prescriber.
Other acute care in Centerville
- Andrea RobinsonCleveland$149K
- Brittney BrowneMonroe$142K
- Jamie McGuireMiamisburg$86K
- Ileah ReichertColumbus$73K
- Davida PraterBeavercreek$46K
- Dawn FrenchAlliance$40K
- Holly McKibbenColumbus$23K
- Jody HussBlue Ash$13K
- Julie LurieCincinnati$13K
- Susan BrooksMount Vernon$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.